Upgrade to SI Premium - Free Trial

Rocket Pharmaceuticals (RCKT) PT Lowered to $2.95 at Jefferies

October 7, 2026 4:49 AM
Jefferies analyst Andrew Tsai lowered the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $2.95 (from $4.25) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change